Health TrialsbyHealthPanel

Lewy Body Dementia Psychosis

2

Review clinical trials related to Lewy Body Dementia Psychosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

Participants needed: 126
Trial details
Phase: Phase 3Age: 55-84Biological sex: AllType: InterventionalSponsor: ACADIA Pharmaceuticals Inc.Updated: Sep 29, 2026Locations: 32
Eligibility criteria

The subject may benefit from long-term therapy with open-label ACP-204 treatment... [+9]

Is judged by the Investigator or the Medical Monitor to be inappropriate for the... [+8]

Read more
Status: Recruiting

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Multicenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.

Participants needed: 180
Trial details
Phase: Phase 2Age: 55-84Biological sex: AllType: InterventionalSponsor: ACADIA Pharmaceuticals Inc.Updated: Sep 29, 2026Locations: 61
Eligibility criteria

Male or female ≥55 years to <85 years of age at the Screening visit living in th... [+4]

Is in hospice, is receiving end-of-life palliative care, or is bedridden [+4]

Read more